about
Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitorsBench-to-bedside review: fulfilling promises of the Human Genome ProjectUniversal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUSHyperoxia toxicity after cardiac arrest: What is the evidence?The rate of brain death and organ donation in patients resuscitated from cardiac arrest: a systematic review and meta-analysisFrench Intensive Care Society, International congress - Réanimation 2016Proceedings of Réanimation 2017, the French Intensive Care Society International Congress[Epidemiology, prognostic data of cardiac arrest in 2014].[Epidemiology: Data from France and USA].Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unitBrainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality.Plasma thioredoxin levels during post-cardiac arrest syndrome: relationship with severity and outcome.Increased survival of cirrhotic patients with septic shock.Targeted temperature management in the ICU: guidelines from a French expert panel.Gender and survival after sudden cardiac arrest: A systematic review and meta-analysis.Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine.Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.The era of genomics: impact on sepsis clinical trial design.Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns.Risk factors for post-ICU red blood cell transfusion: a prospective study.Timing and causes of death in septic shock.Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?Adjunctive therapies in sepsis: an evidence-based review.Breakthrough in cardiac arrest: reports from the 4th Paris International Conference.Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.Association of REL polymorphisms and outcome of patients with septic shock.Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trialAre clinical trials dealing with severe infection fitting routine practices? Insights from a large registry.Extra-hematopoietic effects of erythropoietin.Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoringToward theragnostics.Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era.Benefit of an early and systematic imaging procedure after cardiac arrest: insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) registry.Predictors of external cooling failure after cardiac arrest.Management of postcardiac arrest myocardial dysfunction.Impact of organizational culture on preventability assessment of selected adverse events in the ICU: evaluation of morbidity and mortality conferences.Should we perform a coronary angiography in all cardiac arrest survivors?Out-of-hospital cardiac arrest from brain cause: epidemiology, clinical features, and outcome in a multicenter cohort*.Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
P50
Q24794857-A4C2A0B9-179D-4885-A242-EC29D432BE72Q24798503-76C533A0-0A08-4C30-9AEA-CCF972072FD3Q24805414-B00E00DF-24D5-43D9-AD52-DB4289909F01Q26744214-A07094B7-0F3D-44C0-AE5B-6F5723E190F3Q26752783-75A2B751-FE03-4C20-8A82-73A5943335F6Q28079833-98A8EFD9-A1BF-48FC-815C-DC5C978BF0E6Q28550357-3FC97ECB-ED6F-44A1-8837-2B9794CD7116Q28564101-02F4F5E5-141B-4889-8791-1ABF529D85E1Q30828494-3DB949B7-36F8-4D69-B4F4-492E907A526FQ31132913-4348B577-A88D-4F43-97AF-C7368684AA73Q33427993-EC726592-F9F1-4820-B9CB-36FE6644C41DQ33602499-AC2D65C6-A3E0-4142-BEF2-29E35430E162Q33752742-6CE1FA77-41AD-4FFC-97DE-92AF1FB01E37Q33754347-9DEFA2A7-F147-4A1E-90AD-3BD7F8801E3BQ33812414-8E150D4C-DD79-4BB9-91D1-D8ACAFDA7BF1Q34483482-69436A45-0595-4C61-A963-E968E397C09EQ34553537-0B5AAEBF-A547-4D21-B7C1-85560F7B46D8Q34633612-DEA8EDA1-F023-4256-B0A0-9F1CBED28D9DQ34633623-C9A0D8BE-BBBB-47AF-8F7E-03ECBEE1EA1AQ34681867-E903E1B1-CB44-4B3B-8A01-85B46DE1F860Q35544790-1178A905-9169-4D87-895F-32802D05166FQ35761868-8735BA0D-2388-4728-9C8D-A1CEA85D48F8Q35786349-6867F843-36E6-4217-8F42-6F2BCE6C728AQ35948822-4CA5DED9-070F-4FDB-94F3-3D68FA70A55DQ36070123-56F6168F-9777-48F4-8250-B83E40448518Q36634020-E6E87EDF-1120-400B-8CBD-8494AA4556A6Q36782952-B4A8DEEE-C887-46A5-987F-A149FB5A816CQ36877358-3EA5F060-CB83-4433-B680-C1BAB23EE188Q36998459-94A094E9-DE97-40C7-800F-4964FAFE96DDQ37264692-6A5F065D-BC62-48FF-B128-1F080203E77DQ37279791-EF8B23F1-5FA6-4350-9467-CFCD2157FF5FQ37356889-CFC21C84-8FE3-4759-AC13-4B81C724D98AQ37845100-640E3DBE-03F3-4AF6-9C47-7DFB3850CBFEQ38037983-2CA9BFDF-EA0E-41F3-BA2D-512ECBA1C06CQ38072343-F90921EE-D141-4281-973C-23611B888E47Q38091237-9BE867FE-EA82-4512-88A4-82A6125932F2Q38098471-9E278B98-EF0A-4E0C-B3B3-B8D6A0C33BC3Q38208477-8F3CDEAB-7EFA-4B17-A17D-9C92687A7A93Q38323247-9B969C2F-F460-40FD-BC7D-F249430A8D29Q38376133-BBACCDF1-D95D-434B-A5A1-FB4E26157BF9
P50
name
Alain Cariou
@en
Alain Cariou
@nl
type
label
Alain Cariou
@en
Alain Cariou
@nl
prefLabel
Alain Cariou
@en
Alain Cariou
@nl